254 related articles for article (PubMed ID: 17260091)
1. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
3. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
Le Marchand L; Haiman CA; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
[TBL] [Abstract][Full Text] [Related]
4. The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan.
Lin WY; Chou YC; Wu MH; Huang HB; Jeng YL; Wu CC; Yu CP; Yu JC; You SL; Chu TY; Chen CJ; Sun CA
Anticancer Res; 2004; 24(6):3863-8. PubMed ID: 15736423
[TBL] [Abstract][Full Text] [Related]
5. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
[TBL] [Abstract][Full Text] [Related]
7. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
8. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
9. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
11. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study.
Le Marchand L; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1198-203. PubMed ID: 15894672
[TBL] [Abstract][Full Text] [Related]
12. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
13. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population.
Deligezer U; Akisik EE; Dalay N
In Vivo; 2005; 19(5):889-93. PubMed ID: 16097444
[TBL] [Abstract][Full Text] [Related]
14. The methylenetetrahydrofolate reductase 677C-->T polymorphism and lung cancer risk in a Chinese population.
Jeng YL; Wu MH; Huang HB; Lin WY; You SL; Chu TY; Chen CJ; Sun CA
Anticancer Res; 2003; 23(6D):5149-52. PubMed ID: 14981981
[TBL] [Abstract][Full Text] [Related]
15. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
Lewis SJ; Harbord RM; Harris R; Smith GD
J Natl Cancer Inst; 2006 Nov; 98(22):1607-22. PubMed ID: 17105984
[TBL] [Abstract][Full Text] [Related]
16. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
Li D; Ahmed M; Li Y; Jiao L; Chou TH; Wolff RA; Lenzi R; Evans DB; Bondy ML; Pisters PW; Abbruzzese JL; Hassan MM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1470-6. PubMed ID: 15941958
[TBL] [Abstract][Full Text] [Related]
17. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
Chen J; Gammon MD; Chan W; Palomeque C; Wetmur JG; Kabat GC; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Santella RM
Cancer Res; 2005 Feb; 65(4):1606-14. PubMed ID: 15735051
[TBL] [Abstract][Full Text] [Related]
18. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene.
Beilby J; Ingram D; Hähnel R; Rossi E
Eur J Cancer; 2004 May; 40(8):1250-4. PubMed ID: 15110890
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis.
Zintzaras E
Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
